The Broken Brokerage Model: Why Commission Hurts Clinic Strategy

You find the perfect site. Strong demographics, great visibility, landlord is responsive.

Then your broker tells you to move fast: raise your offer, shorten contingencies, make the deal cleaner for the landlord.

You agree. The lease gets done.

Six months later:

  • Permitting takes 3 months longer than expected—and you removed your right to extend
  • Rent started before you could open—you're burning $50K paying for empty space during construction
  • Worse: if the permit doesn't come through, you're stuck with a 10-year lease you can't use
  • Your only options: spend hundreds of thousands fighting the city, or walk away from a signed obligation

The result: Your broker got paid when the lease signed. You're the one dealing with the fallout.

This isn't bad luck. It's what happens when your advisor gets paid to close deals, not protect your timeline and capital.

The Incentive Problem Is Structural, Not Personal

Traditional brokerage compensation is contingency-based and tied to transaction value. Bigger deal, longer term, faster path to signature. The broker doesn't get paid for getting you the best deal, they get paid for getting the deal done.

That structure doesn't automatically produce bad advice, but it does create predictable bias: reduce friction, maintain momentum, get the lease signed.

For a healthcare operator, that's dangerous. Your job isn't to win a deal. Your job is to make sure the site can support patient flow, staffing, licensing, privacy, infrastructure, and long-term flexibility. A healthcare site is more than an address. It's a clinical operating system in physical form.

The U.S. Brokerage Model

The U.S. is unique in that landlords pay tenant brokers. In many international markets, landlords and tenants each pay their own brokers. This creates a structural quirk: your "free" broker isn't actually working for you—they're working for whoever signs their commission check.

The wrong site can look efficient in a tour, competitive in an LOI, and still become a cash drain after signature. We see this most often when operators confuse a good corner, strong demographics, or landlord responsiveness with true healthcare readiness.

Where the Misalignment Shows Up Before You Even Sign

1. Deal Size Determines Attention Level

Every operator we speak with questions their broker's motives. And the pattern is consistent across deal sizes:

Small deals (individual clinics, sub-5,000 sq.ft.): You get a senior broker's name on the email signature, but the actual work gets pawned off to someone new to the industry. Why? The fees are tiny compared to larger deals. Your 2,500 sq.ft. urgent care doesn't justify senior-level attention when they can work a 50,000 sq.ft. medical office building lease instead.

Large deals (flagship locations, multi-site portfolios): You get broker attention—but not necessarily the best deal. In competitive markets for high-profile spaces, having a broker with deep relationships matters. But relationships optimize for access and speed, not necessarily for protecting your downside or structuring the lease to support your operations in year 7.

Real example: An operator expanding to their third location worked with a well-connected broker who secured a meeting with a hard-to-reach landlord. The broker positioned it as a win. And it was—for deal access.

But the lease terms were landlord-favorable across the board: minimal TI, tight contingencies, no flexibility on future expansion rights. The broker's value was getting them in the room. Our value was making sure they didn't accept a deal that looked good on day one but constrained them for the next decade.

This isn't a critique of all brokers. Many work hard and care about outcomes. But when your "free" representation is optimized for transaction volume or relationship preservation, don't be surprised when strategic protection takes a back seat.

2. Price Pressure Replaces Strategic Discipline

One of the clearest signals is emotional pressure around the deal itself. A broker tells you the building is a "home run." Then comes the next step: raise your offer, move faster, make the proposal more aggressive.

The reality: A site can absolutely be a home run on location and still be a flawed healthcare deal. If the infrastructure is weak, the path to medical use is difficult, or the build-out is unusually expensive, "winning" the deal just means you won the right to take on more risk.

We'd rather lose a shiny site than win a lease that quietly blows up the pro forma six months later.

3. Contingencies Get Treated Like Obstacles

The most dangerous version shows up at the LOI stage. To make your offer more attractive, you're asked to shorten diligence periods, reduce regulatory contingencies, compress permitting timelines, or remove protections that feel inconvenient to the landlord.

The permit contingency trap: We've seen operators pressured to reduce permit contingency periods or remove the right to extend "to make the deal cleaner." They agree. The lease gets done.

Then permitting takes longer than expected. Rent starts while they're still in construction—burning $15K-$50K per month on empty space. Worse: if the permit doesn't come through at all, they're stuck with a 10-year obligation on a site they can't open, facing either a six-figure fight with the city or walking away from a signed lease.

That's not hypothetical. We've watched this exact scenario play out multiple times.

Office tenants can absorb some ambiguity. Healthcare operators can't. You're building a clinical system under regulatory constraints that punish bad assumptions, and you need to maximize your flexibility to ensure you don't make a seven-figure mistake that jepoardizes your entire operation.

Why This Is More Dangerous in Healthcare

When operators move too fast in healthcare real estate, the consequences hit three times: in capital, in timeline, and in operations.

Real Estate Impact

You can't let LOI speed outrun diligence. The wrong shortcut at the front end creates a site that's harder to permit, harder to build, and harder to run.

What this means for your next lease:

  • Zoning or medical-use friction can delay launch long after the lease is signed
  • Undervetted infrastructure can trigger major HVAC, plumbing, or electrical upgrades during design
  • Weak contingency language can leave you holding a long-term obligation on a site you can't open
  • Lease terms optimized for "winning the deal" can limit flexibility when your care model evolves

And even when the deal technically works, you can still lose strategically. Operators end up over-spaced, over-rented, or locked into terms that limit future flexibility.

"In healthcare real estate, the risk isn't that your broker is malicious. It's that they're paid to close, while you're the one who has to operate the space."

The Better Model: Alignment Over Transaction

The right question isn't whether brokers are good or bad. The right question is: who owns the strategy?

If your real estate lead is compensated primarily when the deal closes, expect transaction bias. If your advisor is retained to protect your capital and guide the full process, you get different behavior.

Contingency-Based Broker

The transaction is the finish line. Advice tends to favor momentum, cleaner LOIs, less friction, and a faster path to signature. That can work for simple deals. It's a weak model for complex healthcare expansion.

Retained Strategic Partner

The operating outcome is the finish line. Advice can favor smaller footprints, deeper diligence, tougher questions, and walking away from bad sites—because the goal isn't to get paper signed. The goal is to build a viable clinical model.

That's the core value of a retained advisory model. We understand the constraints of the real work that happens after the walls are up, and we try to make sure operators don't commit to the wrong one.

This changes how we evaluate risk, how we negotiate contingencies, how we source options, and how quickly we're willing to move.

Sometimes that means pushing harder. Sometimes it means slowing the process down. Sometimes it means killing a deal that looks exciting on paper.

In healthcare, discipline is often what preserves speed later. Operators need someone willing to challenge the deals before they're signed.

What About Tenant-Rep Firms?

Not all brokers operate under the same model. Tenant-rep brokerage firms work exclusively for tenants, which creates better structural alignment.

They're still paid on contingency (commission at lease signature), which means transaction bias still exists. We've found that because they don't also represent landlords, there's a stronger bias towards aggressively negotiating for tenant-favorable terms or walking away from bad deals.

Just understand that "better alignment" isn't the same as "perfectly aligned." The finish line is still the signed lease, not your operational success in year 5.

The Bottom Line

The broken part of the brokerage model isn't that every broker gives bad advice. It's that operators assume the person moving the deal forward is also protecting the strategy. In healthcare, those aren't automatically the same thing.

For healthcare operators: If you outsource site strategy to a transaction-based model, don't be surprised when the process prioritizes speed over diligence and signature over long-term fit.

For growth-stage operators: The more sites you plan to build, the more expensive this misalignment becomes. One bad lease doesn't stay one bad lease—it compounds across capital planning, operations, and future rollout decisions.

Before You Sign the Next LOI, Stress-Test the Strategy

We help healthcare operators evaluate sites the way operators should, not the way transactions usually do.

We'll walk through:

  • Whether the site actually supports your care model and throughput goals
  • Which diligence items need protection before you commit in the LOI
  • Where infrastructure, entitlement, or permitting risk may be hiding
  • How to structure the lease so deal speed doesn't sacrifice long-term viability
Schedule a Strategy Session
Previous
Previous

The Second Site Paradox: Why 1 + 1 Equals 0.5 in Clinic Growth

Next
Next

LOI & Lease Negotiation: Protecting EBITDA, Exit Value, and Founder Equity